SynthesisFrontiers in oncology2026
Immune checkpoint inhibitor-based combination therapy for platinum-resistant or platinum-refractory recurrent ovarian cancer: a systematic review and meta-analysis of prospective trials.
Jing Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.